Evidence map›Paper›PMID 42327424›Full record

ArticleNPJ dementia2026

Contextual variability in under-diagnosed cardiometabolic disease and cognitive vulnerability among populations at high risk for Alzheimer's disease and related dementias.

Nwanyieze Ngozi Jiakponnah, Joseph Curran, Tamlyn Watermeyer, Jasmit Shah, Litha Musili, Stanley Onyango, Benard Aliwa, Andy Mackelfresh, Omonigho Michael Bubu, Chiadi Onyike and 10 more

Abstract read
In one paragraph

Article in NPJ dementia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Nwanyieze Ngozi Jiakponnah *Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC USA.
Joseph Curran *Department of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC USA.
Tamlyn Watermeyer *School of Psychology, University of Northumbria, Newcastle, UK.
Jasmit ShahImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Litha MusiliImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Stanley OnyangoImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Benard AliwaImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Andy MackelfreshUniversity of North Carolina, Charlotte, NC USA.
Omonigho Michael BubuDepartments of Psychiatry, Neurology & Population Health, NYU Grossman School of Medicine, New York, NY USA.
Chiadi OnyikeDivision of Geriatric Psychiatry and Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, USA.
Ozioma OkonkwoSchool of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI USA.
Zul MeraliImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Rufus AkinyemiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Timothy HughesDepartment of Internal Medicine, Section on Gerontology and Geriatrics Medicine, Wake Forest University School of Medicine, Winston-Salem, NC USA.
Mansoor SalehCancer Research Unit, Aga Khan University, Nairobi, Kenya.
Melissa PetersenInstitute for Translational Research, University of North Texas Health Science Center, Fort Worth, TX USA.
Karen BlackmonImarisha Center for Brain Health and Aging, Brain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Adesola OgunniyiNeuroscience and Ageing Research Unit, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Hugh HendrieIndiana University School of Medicine, University of Indiana, Indianapolis, IN USA.
Chinedu Udeh-MomohDepartment of Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, NC USA.

Funding

Research Education ComponentP30AG066512 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Arline Faustin · 2020 to 2026
$28.4M
Using a Health Disparity Research Framework to examine mechanisms linking Obstructive Sleep Apnea with higher Alzheimer’s disease risk in older Blacks/African-AmericansR01AG082278 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI OMONIGHO A MICHAEL Bubu · 2023 to 2026
$6.9M
Treatment of OSA on sleep-dependent memory and blood biomarkers in blacksRF1AG083975 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI OMONIGHO A MICHAEL Bubu, Korey Kam · 2023 to 2026
$4.2M
The mediating role of Slow Wave Sleep and Vascular Risk Factors on Alzheimer Disease related disparity between African-Americans and non-Hispanic WhitesK23AG068534 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BUBU, OMONIGHO A MICHAEL · 2021 to 2025
$958k
NIA NIH HHS K23 AG068534NIA NIH HHS L30 AG064670NIA NIH HHS P30 AG066512NIA NIH HHS R01 AG082278NIA NIH HHS RF1 AG083975
6 · The paper itself

Abstract

Underdiagnosis of cardiometabolic risk factors (CMRFs) may represent an unrecognised biological pathway contributing to dementia risk; yet remains poorly characterised in African and African diaspora populations. We quantified the prevalence and determinants of underdiagnosed hypertension and abnormal glycaemia across four cohorts comprising up to 7000 adults aged ≥40 years from Nigeria, Kenya, and The United States: Indianapolis, and North Texas. Underdiagnosis was defined as absence of self-reported diagnosis despite elevated systolic blood pressure ( ≥130 mmHg) or fasting blood glucose ( ≥100 mg/dL). Cohort-stratified analyses examined demographic, socioeconomic, cognitive, Alzheimer's genetic, and blood-based biomarker correlates. Underdiagnosis was pervasive in African cohorts. Elevated fasting glucose was associated with cognitive impairment in Kenya and North Texas, while severe hypertension and diabetes were linked to Alzheimer's disease-related biomarkers [pTau217/181, NFL and Aβ42/40] in North Texas (

Indexed as

BiomarkersDiseasesNeurologyNeuroscienceRisk factors

Identifiers

PMID42327424
PMCPMC13282169

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.